Skip to main content
OpenTrials

Clinical trial condition

Depressive Disorder

Explore clinical trials studying Depressive Disorder. Study availability and eligibility vary by location and protocol.

2,799 public trials 431 recruiting studies
Refine in advanced search Browse all conditions

Depressive Disorder trial results

Completed

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

NCT00411099

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Novartis Investigative Site Scottsdale, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Cerritos, California, United States
  • Novartis Investigative Site El Centro, California, United States
View all 44 locations
View Trial Details
Completed

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder

NCT01110889

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Birmingham Psychiatry Birmingham, Alabama, United States
  • Southwestern Research Institute Beverly Hills, California, United States
  • Pharmacology Research Institute Encino, California, United States
  • Mood & Anxiety Research Fresno, California, United States
View all 48 locations
View Trial Details
Completed

Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder

NCT00467402

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Peoria, Arizona, United States
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Beverly Hills, California, United States
View all 78 locations
View Trial Details
Completed

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

NCT00411242

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Novartis Investigative Site Mesa, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Oceanside, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 51 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder

NCT03446846

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Woodland International Research Group, LLC Little Rock, Arkansas, United States
  • Collaborative Neuroscience Network, LLC Garden Grove, California, United States
  • Collaborative Neuroscience Network, LLC Torrance, California, United States
  • Pacific Clinical Research Medical Group Upland, California, United States
View all 47 locations
View Trial Details

Related conditions